Key Takeaways: Daxxify vs Botox
Both Daxxify and Botox are FDA-approved neuromodulators that relax facial muscles to reduce dynamic wrinkles.
Botox (onabotulinumtoxinA) has been used safely in cosmetic medicine for over three decades.
Daxxify (daxibotulinumtoxinA-lanm) is a newer, peptide-powered neuromodulator with potentially longer-lasting results.
Daxxify typically lasts 6 months or more, while Botox averages 3–4 months.
There is no universally superior treatment—the right choice depends on your anatomy, muscle activity, and aesthetic goals.
Experienced injectors at CosmeSurge help patients choose the most suitable wrinkle treatment through a thorough facial assessment.
If you are considering injectable wrinkle treatment, you have probably come across two names: Botox and Daxxify. Both are botulinum toxin type A neuromodulators. Both are FDA-approved. And both are available at leading aesthetic clinics worldwide.
But there are meaningful differences between them – particularly in how long they last, how they are formulated, and who benefits most from each.
This guide breaks down the daxxify vs botox debate with clinical accuracy and practical guidance so you can make an informed decision about your wrinkle treatment.
What Is Daxxify?
Daxxify is an injectable neuromodulator developed by Revance Therapeutics and approved by the FDA in September 2022. Its active ingredient is daxibotulinumtoxinA-lanm – a purified form of botulinum toxin type A stabilized with a proprietary peptide excipient called RTP004, rather than the human serum albumin used in older formulations like Botox.
What is Daxify? The spelling ‘Daxify’ is a common patient search variation. Both Daxify and Daxxify refer to the same FDA-approved treatment. It represents one of the most clinically significant innovations in botulinum toxin aesthetics in recent years.
How Does Daxxify Work?
Like all neuromodulators, Daxxify works by temporarily blocking acetylcholine release at the neuromuscular junction. When this neurotransmitter cannot reach the muscle, it cannot contract – and the skin above it relaxes, reducing the appearance of dynamic wrinkles caused by facial movement.
The distinguishing feature is the RTP004 peptide. This stabilizer keeps the botulinum toxin molecule more stable after injection and is thought to enhance binding to nerve terminals – which is believed to explain Daxxify’s extended duration of action compared to other neuromodulators.
Daxxify FDA Approval and Approved Indications
Daxxify is FDA-approved for the treatment of moderate to severe glabellar lines (the vertical frown lines between the eyebrows) in adults. Clinical research is ongoing for additional facial areas and medical conditions including cervical dystonia.
Is Daxxify FDA approved? Yes. It received FDA clearance in September 2022 following the SAKURA clinical program, which enrolled over 2,600 patients across multiple studies to establish its safety and efficacy profile.
What Is Botox?
Botox (onabotulinumtoxinA) is manufactured by Allergan Aesthetics (AbbVie) and is one of the most recognized names in cosmetic medicine. It was approved by the FDA for medical use in 1989 and received cosmetic approval in 2002 for glabellar lines – making it one of the most extensively studied injectable treatments in clinical history.
Botox is stabilized with human serum albumin and sodium chloride. It has been administered hundreds of millions of times globally and carries one of the strongest long-term safety records of any injectable medication currently in use.
How Does Botox Work?
Botox also blocks acetylcholine at the neuromuscular junction. Once injected, the toxin binds to nerve terminals and prevents the release of the neurotransmitter responsible for muscle contraction. The result is temporary, localized muscle relaxation that softens existing wrinkles and prevents new ones from deepening.
Results typically appear within 3-5 days and peak at approximately 2 weeks. Effects generally last 3-4 months in most patients, though those with highly active facial muscles may notice fading as early as 2.5 months.
Botox Cosmetic and Medical Uses
Cosmetic uses include: forehead lines, glabellar lines, crow’s feet, bunny lines, lip lines, platysmal neck bands, brow lifting, masseter reduction (jaw slimming), and chin dimpling.
Medical uses include: chronic migraines, hyperhidrosis (excessive sweating), overactive bladder, cervical dystonia, limb spasticity, and blepharospasm. This breadth of approved use is one of Botox’s most significant advantages over newer neuromodulators.
Daxxify vs Botox: Key Differences
The comparison table below covers the most clinically relevant distinctions between these two treatments:
Feature | Daxxify | Botox |
FDA Approval | September 2022 (cosmetic) | 2002 (cosmetic); 1989 (medical) |
Active Ingredient | DaxibotulinumtoxinA-lanm | OnabotulinumtoxinA |
Stabilizer | Peptide (RTP004) | Human serum albumin |
Onset | 1-3 days (peak: 2 weeks) | 3-5 days (peak: 2 weeks) |
Duration | 6-9 months (average) | 3-4 months (average) |
Cost per Session | Higher per session | Lower per session; more frequent |
FDA-Approved Areas | Glabellar lines (cosmetic) | Forehead, glabella, crow’s feet + medical uses |
Best Candidates | Experienced patients; fewer sessions preferred | First-timers; versatile multi-area use |
These differences form the foundation of the botox vs daxxify decision. The specialists at CosmeSurge guide every patient through these factors during a personalized facial assessment before making any treatment recommendation.
Which Lasts Longer: Daxxify or Botox?
Duration is the single most significant practical difference between these two treatments – and the primary reason many patients are now seeking a new botox that lasts longer or asking about long acting botox alternatives.
Daxxify: In the SAKURA clinical trials, the majority of patients maintained results for 6 months, with a meaningful proportion retaining visible improvement for up to 9 months. The median duration was approximately 24 weeks – roughly double Botox’s average.
Botox: Most patients require retreatment every 3-4 months. Those with very active facial muscles may see results fade as early as 2.5 months. Very few sustain improvement beyond 5-6 months without treatment.
Duration Comparison: Daxxify vs Botox vs Dysport
Neuromodulator | Average Duration | Maximum Observed |
Daxxify | 6 months | Up to 9 months |
Botox | 3-4 months | Up to 6 months (some patients) |
Dysport | 3-4 months | Up to 5 months |
Xeomin | 3-4 months | Up to 5 months |
For patients specifically asking what lasts longer than botox, Daxxify currently represents the most clinically validated longer-acting neuromodulator available in the market.
How Long Does Daxxify Take to Work?
Understanding how long does daxxify take to work helps set realistic expectations before your appointment and allows you to plan around important events.
Daxxify Treatment Timeline
Timepoint | What to Expect |
Day 1 | Injection performed. Minimal downtime. Some patients experience mild redness or swelling at the injection site. |
Days 2-3 | First subtle muscle relaxation begins. Lines may appear slightly softer than before treatment. |
Days 3-5 | Visible softening of glabellar lines in most patients. Results becoming clearly apparent. |
Week 1 | Significant improvement in the treated area. Most patients notice clear, visible results. |
Week 2 | Peak results achieved. Full effect visible. Ideal time for follow-up assessment and before-and-after photos. |
Months 2-6+ | Results maintained. Gradual, natural return of muscle movement toward the end of the treatment window. |
How long does it take for daxxify to work overall? For most patients: 3-5 days for visible results and 2 weeks for full peak effect. This timeline is consistent with Botox and other neuromodulators.
Daxxify vs Botox Cost
Daxxify vs botox cost is one of the most practical questions patients ask when weighing their options. Daxxify typically costs more per session – often ranging from $600 to $1,200 or more depending on the clinic, location, and number of units used. A standard Botox glabellar treatment generally costs between $300 and $600.
However, the annualized cost comparison often narrows this gap considerably. If Botox requires 3-4 sessions per year and Daxxify requires just 1-2, the total annual investment becomes comparable – or even favourable for Daxxify in some cases.
At CosmeSurge, all pricing is discussed transparently during a personalized facial assessment. Costs depend on the number of units required and the specific areas being treated.
Daxxify Units vs Botox Units
A frequent source of patient confusion is the unit system. Both Daxxify and Botox are measured in units, but daxxify units vs botox units are not interchangeable – they are different biological preparations with different dose-response relationships.
In clinical trials for glabellar lines, Daxxify was studied at 40 or 60 units (with 40 units sufficient for most patients). A comparable Botox treatment might use 20 units. This does not mean Daxxify is twice as potent – it means the unit systems are independently calibrated for each product.
A skilled injector calculates the correct dose for each product based on individual muscle mass, facial anatomy, and desired outcome – never by converting units from one neuromodulator brand to another.
Daxxify Before and After: What to Expect
Clinical data from the SAKURA program provides a reliable picture of what patients can expect from Daxxify before and after treatment:
The majority of patients achieved ‘none’ or ‘mild’ glabellar line severity at peak assessment.
Daxxify results appear natural and proportionate when correctly dosed – not frozen or overdone.
Patient satisfaction scores were consistently high, with most participants reporting they would choose Daxxify again.
The visual aesthetic outcome is similar to Botox in terms of wrinkle reduction and facial expression.
The primary difference experienced patients notice is longevity: Daxxify results hold noticeably longer before gradual muscle movement returns.
Daxxify reviews from clinical trial participants consistently highlight satisfaction with both results and the extended treatment-free interval. When administered by an experienced injector, the aesthetic outcome is smooth, rested, and natural-looking.
Is Daxxify Safe?
Is daxxify safe? Yes. It is FDA-approved with an established safety profile from the SAKURA clinical program, which enrolled over 2,600 patients across multiple study phases. The safety data from Daxxify injections is consistent with other FDA-approved botulinum toxin products.
Daxxify is not recommended for the following patients:
Pregnant or breastfeeding patients
Individuals with known hypersensitivity to botulinum toxin or any product component
Patients with neuromuscular disorders such as myasthenia gravis or Lambert-Eaton syndrome
Those taking aminoglycoside antibiotics or other agents that may potentiate neuromuscular blockade
Side Effects of Daxxify vs Botox
Both treatments share a broadly similar side effect profile, as both are botulinum toxin type A formulations injected into facial muscles. The table below reflects data from clinical trials and post-market experience:
Side Effect | Daxxify | Botox |
Headache | Common | Common |
Injection site bruising | Common | Common |
Injection site swelling | Common | Common |
Eyelid drooping (ptosis) | Rare | Rare |
Facial asymmetry | Very rare | Very rare |
Nausea | Occasional | Occasional |
Antibody formation | Not fully characterized | Rare with standard dosing |
Duration of side effects | Self-resolving | Self-resolving |
All known side effects of both Daxxify and Botox are temporary and self-resolving. The risk of serious adverse events is low when treatments are performed by trained, experienced aesthetic physicians.
Is Daxxify Better Than Botox?
Is daxxify better than botox? There is no universal answer. Both treatments are clinically effective. The right choice depends entirely on individual patient goals, anatomy, lifestyle, and treatment history. Making it clear: there is no one-size-fits-all recommendation when comparing these two highly effective neuromodulators.
Daxxify May Be the Better Choice If:
You want fewer treatment sessions per year
You have strong facial muscles and find Botox wears off faster than average
You travel frequently or have a demanding schedule that makes regular appointments difficult
You are an experienced neuromodulator patient who knows how your face responds
You are seeking a new form of botox with longer duration without switching treatment categories
Botox May Be the Better Choice If:
You are new to neuromodulator treatments and want to start with a shorter commitment
You want treatment across multiple facial areas in a single session
You prefer a lower per-session upfront cost
You need a neuromodulator for a medical condition such as migraines or hyperhidrosis
You value over 35 years of extensive post-market safety data and broad physician experience
The personalized wrinkle treatment plans at CosmeSurge are built around each patient’s individual facial anatomy, muscle activity, and lifestyle – not a one-size-fits-all recommendation.
Who Is a Good Candidate for Daxxify?
You may be a strong candidate for Daxxify if:
You have moderate to severe glabellar lines (frown lines between the eyebrows)
You have previously used Botox or another neuromodulator and been satisfied with the results
You want longer intervals between treatment appointments
You have strong glabellar muscles and typically find Botox results fade faster than you would like
You are in good general health and are not pregnant, breastfeeding, or taking contraindicated medications
Who Should Choose Botox Instead?
Botox remains the right starting point for many patients, particularly those who:
Are new to injectable wrinkle treatments and want to assess their response before committing long-term
Need treatment across multiple facial areas in a single session
Require a neuromodulator for an approved medical indication
Are working within a per-session budget and prefer a lower upfront cost
Receive anti-wrinkle injections alongside dermal fillers or other facial rejuvenation treatments
Prefer a product with decades of established post-market safety evidence
Daxxify vs Dysport vs Botox
Multiple neuromodulators are available for aesthetic treatment. The table below extends the comparison to include Dysport – another widely used botulinum toxin type A injectable and one of Botox’s primary botox competitors:
Feature | Daxxify | Botox | Dysport |
Active Ingredient | DaxibotulinumtoxinA-lanm | OnabotulinumtoxinA | AbobotulinumtoxinA |
FDA Approval Year | 2022 | 2002 | 2009 |
Duration | 6-9 months | 3-4 months | 3-4 months |
Onset | 1-3 days | 3-5 days | 1-3 days |
Units (glabella) | 40-60 units | ~20 units | 50-60 units |
Diffusion/Spread | Moderate | Moderate | Wider |
Best For | Longevity seekers | Versatility; first-timers | Quick onset; crow’s feet |
Each product carries distinct advantages. Dysport diffuses slightly more broadly, which some injectors favour for certain areas. Daxxify leads on duration. Botox leads on versatility and the depth of long-term clinical data available globally.
Common Myths About Daxxify
Myth: Daxxify replaces Botox.
Fact: Both remain highly effective neuromodulators with different clinical advantages. Daxxify is an additional treatment option – not a replacement for Botox or other established products.
Myth: Longer-lasting means stronger or more frozen-looking.
Fact: Duration and potency are entirely separate concepts. Daxxify at the appropriate dose produces natural, balanced muscle relaxation comparable in appearance to Botox.
Myth: Daxxify is experimental or unproven.
Fact: Daxxify is fully FDA-approved and backed by the SAKURA program – one of the most comprehensive botulinum toxin development programs ever conducted, with over 2,600 trial participants.
Myth: Daxxify units and Botox units are interchangeable.
Fact: Units are calibrated independently for each neuromodulator brand. Your injector calculates the correct dose for each product separately based on your individual anatomy.
Myth: Daxxify is only suitable for severe wrinkles.
Fact: Daxxify is FDA-approved for moderate to severe glabellar lines. Off-label applications may be considered by experienced injectors based on individual clinical assessment.
Conclusion
Both Daxxify and Botox are highly effective, FDA-approved treatments for dynamic facial wrinkles. They share the same core mechanism – temporary muscle relaxation via botulinum toxin type A – but differ meaningfully in formulation, duration, cost structure, and approved indications.
Botox brings unmatched clinical history, versatile approved uses across the face and body, and decades of post-market safety evidence. Daxxify brings a novel peptide-powered formula and clinical evidence of results lasting up to 9 months in suitable candidates – a meaningful advance for patients who want fewer annual treatments.
The ideal treatment is not the same for every patient. It depends on facial anatomy, muscle activity, aesthetic goals, treatment history, and lifestyle preferences. A combination approach using anti-wrinkle injections alongside dermal fillers or other facial rejuvenation treatments may also be considered for comprehensive outcomes.
If you are weighing up daxxify vs botox or exploring advanced neuromodulator treatments including Dysport, Xeomin, or combination anti-ageing approaches, the best starting point is a personalized consultation with an experienced aesthetic physician. Advanced neuromodulator treatments are available at CosmeSurge, performed by specialist injectors who design every treatment plan around your individual face.
Book your consultation at CosmeSurge today and take the first step toward results that work with your lifestyle.
Frequently Asked Questions About Daxxify vs Botox
Here are some answers to the specific questions we often hear but didn’t cover in detail above.
Daxxify (daxibotulinumtoxinA-lanm) is an FDA-approved injectable neuromodulator developed by Revance Therapeutics. It temporarily relaxes facial muscles to reduce moderate to severe glabellar lines. Distinguished by its proprietary peptide stabilizer (RTP004), which replaces the human serum albumin used in older formulations, Daxxify received FDA approval in September 2022 following the comprehensive SAKURA clinical program.
Not universally. Daxxify offers longer-lasting results – typically 6-9 months versus Botox’s 3-4 months – making it ideal for patients who prefer fewer treatments per year. Botox has broader FDA-approved indications, decades of safety data, and a lower per-session cost. For first-time patients or those requiring multi-area treatment, Botox remains an excellent starting point. The best choice depends on individual goals, anatomy, and budget.
Daxxify typically lasts 6 months on average, with some patients seeing results for up to 9 months. This is based on SAKURA clinical trial data, which reported a median duration of approximately 24 weeks. Individual results vary – patients with very strong facial muscles may notice fading closer to 4-5 months, while others maintain visible improvement significantly longer.
Daxxify typically begins to show visible effects within 2-3 days of injection. Most patients notice meaningful softening of their glabellar lines within the first week, with peak results at approximately 2 weeks post-treatment. This onset timeline is comparable to Botox and other neuromodulators. Your injector may schedule a follow-up at 2 weeks to confirm full effect.
Yes. The FDA approved Daxxify in September 2022 for the treatment of moderate to severe glabellar lines in adults. Manufactured by Revance Therapeutics, it underwent the SAKURA clinical program – one of the largest botulinum toxin development programs ever conducted – enrolling over 2,600 patients across multiple studies establishing both safety and efficacy.
Yes. Daxxify is FDA-approved with a well-characterized safety profile from large-scale trials. The most commonly reported side effects are headache, injection site bruising, and temporary swelling – all self-resolving. Rare side effects such as eyelid drooping can occur with any neuromodulator and are related to injection technique. Daxxify is not recommended during pregnancy, breastfeeding, or in patients with certain neuromuscular conditions.
Daxxify typically costs between $600 and $1,200 per session, depending on the clinic, location, and number of units required. While higher per session than Botox, the extended 6-9 month duration means fewer annual treatments – making the yearly cost comparable for many patients. At CosmeSurge, pricing is discussed transparently during the initial consultation based on your individual treatment plan.
The primary differences are formulation and duration. Daxxify uses a peptide stabilizer (RTP004) rather than human serum albumin, and lasts 6-9 months compared to Botox’s 3-4 months. Botox has a broader range of FDA-approved indications including medical uses, and over three decades of clinical history. Both are botulinum toxin type A treatments that relax muscles and reduce dynamic wrinkles with similar onset timelines.
Daxxify lasts longer than Botox. Clinical evidence shows Daxxify maintains results for an average of 6 months, with some patients seeing effects for up to 9 months. Botox typically lasts 3-4 months. This makes Daxxify particularly attractive for patients wanting fewer annual appointments. Individual results vary based on muscle activity, dosage, metabolism, and the area treated.
Yes. Most patients can transition from Botox to Daxxify once their current treatment has fully worn off. It is generally advisable to wait until all muscle movement has returned before starting Daxxify, to avoid overlapping effects. Your injector will review your treatment history, assess current facial muscle activity, and tailor the dose accordingly. Many experienced Botox users find Daxxify a natural next step when extended duration is a priority.
For many patients, yes. Daxxify’s extended 6-9 month duration is a meaningful lifestyle benefit for those who find quarterly Botox appointments inconvenient. While the per-session cost is higher, annual cost is often comparable when fewer treatment cycles are factored in. Whether it is worth it depends on budget, lifestyle, and individual treatment response. A personalized consultation at CosmeSurge can clarify whether Daxxify aligns with your goals.
Yes. When administered by a skilled injector at an appropriate dose, Daxxify produces natural-looking muscle relaxation – not a frozen or overdone appearance. The aesthetic results are comparable to Botox in terms of wrinkle reduction and facial expression preservation. Natural outcomes depend primarily on injector skill, dose calibration, and understanding of facial anatomy. At CosmeSurge, all neuromodulator treatments are performed by experienced aesthetic physicians trained in balanced, proportional facial outcomes.
Medical Disclaimer & Review
This content is for educational purposes only and does not replace professional medical advice. Always consult a qualified healthcare provider for diagnosis and treatment.
Medically reviewed by the CosmeSurge Dermatology Team, Dubai, UAE.
